Brainsway Ltd (Brainsway) is a medical device company that develops and markets transcranial magnetic stimulation systems and noninvasive medical device for treatment of neurological and psychiatric disorders. The company provides deep transcranial magnetic stimulation products. It offers deep TMS that used for treatment of depressive episodes in adult patients suffering from depressive disorder. Brainsway conducts various clinical research programs. The company also operates online portals for patients, physicians and researchers, among others. It partners with various institutions and researchers in clinical trials covering various neuropsychiatric and neuroscience applications, among others. The company operates in Israel. Brainsway is headquartered in Jerusalem, Israel.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Brainsway Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Brainsway Ltd Company Overview
- Brainsway Ltd Company Snapshot
- Brainsway Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Brainsway Ltd - Pipeline Analysis Overview
- Brainsway Ltd - Key Facts
- Brainsway Ltd - Major Products and Services
- Brainsway Ltd Pipeline Products by Development Stage
- Brainsway Ltd Ongoing Clinical Trials by Trial Status
- Brainsway Ltd Pipeline Products Overview
- Deep TMS System - Accelerated Depression
- Deep TMS System - Accelerated Depression Product Overview
- Deep TMS System - Alcohol Use Disorder
- Deep TMS System - Alcohol Use Disorder Product Overview
- Deep TMS System - Alzheimer's Disease
- Deep TMS System - Alzheimer's Disease Product Overview
- Deep TMS System - Bipolar Disorder
- Deep TMS System - Bipolar Disorder Product Overview
- Deep TMS System - Chronic Pain
- Deep TMS System - Chronic Pain Product Overview
- Deep TMS System - Multiple Sclerosis
- Deep TMS System - Multiple Sclerosis Product Overview
- Deep TMS System - Obesity
- Deep TMS System - Obesity Product Overview
- Deep TMS System - Obesity Clinical Trial
- Deep TMS System - Opioid Use Disorder
- Deep TMS System - Opioid Use Disorder Product Overview
- Deep TMS System - Post-Stroke
- Deep TMS System - Post-Stroke Product Overview
- Deep TMS System - PTSD
- Deep TMS System - PTSD Product Overview
- Next-Generation Multi-Channel TMS Stimulator
- Next-Generation Multi-Channel TMS Stimulator Product Overview
- Rotational Field TMS System
- Rotational Field TMS System Product Overview
- Rotational Field TMS System Clinical Trial
- Brainsway Ltd - Key Competitors
- Brainsway Ltd - Key Employees
- Brainsway Ltd - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Brainsway Ltd, Recent Developments
- Dec 12, 2024: BrainsWay Reports Positive Independent Pilot Data on Accelerated Deep TMS Treatment of Alcohol Use Disorder
- Nov 20, 2024: Brainsway Reports Promising Feasibility Data Showing Pain Reduction with Deep TMS Therapy
- Oct 09, 2024: Brainsway Further Penetrates East Asia With Placement of 15 Additional Deep TMS Systems in Taiwan and South Korea
- Jun 17, 2024: Brainsway Expands Global Imprint with Exclusive Multi-Year Distribution Agreement in Canada
- Jun 13, 2024: Brainsway Received Additional 510(K) Clearance For H7 Deep TMS System
- Jun 10, 2024: Brainsway Launches Prospective, Randomized, Controlled, Multicenter Trial Evaluating Accelerated Deep TMS for Depression
- Jun 03, 2024: BrainsWay Receives Expanded FDA Labeling to Treat Late Life Depression
- Apr 17, 2024: BrainsWay Expands Deep TMS Access in Israel Following Significant Increase in Reimbursement Rates
- Apr 04, 2024: Brainsway Announces Published Review Results Highlighting Potential of Deep TMS to Treat Parkinson’s Disease
- Mar 28, 2024: BrainsWay Announces Positive Results in Late-Life Depression Post-Marketing Analysis
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Brainsway Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Brainsway Ltd Pipeline Products by Equipment Type
- Brainsway Ltd Pipeline Products by Indication
- Brainsway Ltd Ongoing Clinical Trials by Trial Status
- Brainsway Ltd, Key Facts
- Brainsway Ltd, Major Products and Services
- Brainsway Ltd Number of Pipeline Products by Development Stage
- Brainsway Ltd Pipeline Products Summary by Development Stage
- Brainsway Ltd Ongoing Clinical Trials by Trial Status
- Brainsway Ltd Ongoing Clinical Trials Summary
- Deep TMS System - Accelerated Depression - Product Status
- Deep TMS System - Accelerated Depression - Product Description
- Deep TMS System - Alcohol Use Disorder - Product Status
- Deep TMS System - Alcohol Use Disorder - Product Description
- Deep TMS System - Alzheimer's Disease - Product Status
- Deep TMS System - Alzheimer's Disease - Product Description
- Deep TMS System - Bipolar Disorder - Product Status
- Deep TMS System - Bipolar Disorder - Product Description
- Deep TMS System - Chronic Pain - Product Status
- Deep TMS System - Chronic Pain - Product Description
- Deep TMS System - Multiple Sclerosis - Product Status
- Deep TMS System - Multiple Sclerosis - Product Description
- Deep TMS System - Obesity - Product Status
- Deep TMS System - Obesity - Product Description
- Deep TMS System - Obesity - Deep Transcranial Magnetic Stimulation (dTMS) of the Medial Prefrontal Cortex (mPFC) in Food Addiction and Obesity
- Deep TMS System - Opioid Use Disorder - Product Status
- Deep TMS System - Opioid Use Disorder - Product Description
- Deep TMS System - Post-Stroke - Product Status
- Deep TMS System - Post-Stroke - Product Description
- Deep TMS System - PTSD - Product Status
- Deep TMS System - PTSD - Product Description
- Next-Generation Multi-Channel TMS Stimulator - Product Status
- Next-Generation Multi-Channel TMS Stimulator - Product Description
- Rotational Field TMS System - Product Status
- Rotational Field TMS System - Product Description
- Rotational Field TMS System - The Clinical Study to Assess the Safety and Efficacy of Rotational Field TMS System in Rehabilitation Following Stroke
- Brainsway Ltd, Key Employees
- Brainsway Ltd, Subsidiaries
- Glossary
- Brainsway Ltd Pipeline Products by Equipment Type
- Brainsway Ltd Pipeline Products by Development Stage
- Brainsway Ltd Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- InterCure Ltd
- InspireMD Inc
- Biological Signal Processing Ltd
